|
Title
|
Publication Date
|
Price
|
Relevance
|
Bayer Healthcare
Strategic Analysis Profile
|
Feb 2008 |
£500 |
100% |
|
IMS Company Profiles:Bayer
|
Nov 2011 |
£640 |
99% |
|
Pharma Company Profiles - Bayer
|
Oct 2008 |
£255 |
99% |
Bayer
Pipeline, Products ,Performance ,Potential
|
Nov 2010 |
£595 |
99% |
|
Bayer AG: Corporate Analysis
|
May 2008 |
£255 |
99% |
|
Bayer Inc.-Therapeutic Competitors Report
|
Mar 2011 |
£220 |
99% |
|
Bayer Ag-Therapeutic Competitors Report
|
Mar 2011 |
£220 |
99% |
Bayer AG - Medical Equipment
Deals and Alliances Profile
|
Jul 2009 |
£160 |
99% |
|
Bayer AG: OTC Healthcare
|
Oct 2007 |
£195 |
98% |
|
Bayer Corporation-Deals & Alliances Report
|
Mar 2011 |
£380 |
98% |
|
Bayer Schering Pharma AG-Therapeutic Competitors Report
|
Mar 2011 |
£220 |
98% |
|
Bayer Yakuhin, Ltd.-Deals & Alliances Report
|
Mar 2011 |
£380 |
98% |
|
Bayer Innovation GmbH-Deals & Alliances Report
|
Mar 2011 |
£380 |
98% |
|
Bayer CropScience AG-Deals & Alliances Report
|
Mar 2011 |
£380 |
98% |
|
Bayer HealthCare AG-Deals & Alliances Report
|
Mar 2011 |
£380 |
98% |
Bayer AG
Strategy, SWOT, and Corporate Finance Report
|
Jun 2011 |
£79 |
98% |
|
Bayer HealthCare AG Medical Equipment Company Report
|
Mar 2008 |
£630 |
98% |
|
Bayer HealthCare Pharmaceuticals (formerly Bayer Schering Pharma AG)-Detailed Product Pipeline
|
Mar 2011 |
£475 |
98% |
|
Bayer HealthCare Pharmaceuticals Inc. (formerly Berlex, Inc.)-Detailed Product Pipeline
|
Mar 2011 |
£475 |
97% |
Bayer AG - Pharmaceuticals & Healthcare
Deals and Alliances Profile
|
Jul 2009 |
£160 |
97% |
Bayer HealthCare AG - Pharmaceuticals & Healthcare
Deals and Alliances Profile
|
Jul 2009 |
£160 |
97% |
|
Bayer Ag-Deals & Alliances Report
|
Mar 2011 |
£380 |
97% |
|
Bayer HealthCare Pharmaceuticals Inc. (formerly Berlex, Inc.)-Therapeutic Competitors Report
|
Mar 2011 |
£220 |
97% |
|
Partnering Agreements with Bayer 2010
|
Jan 2010 |
£630 |
97% |
|
Bayer HealthCare Pharmaceuticals (formerly Bayer Schering Pharma AG)-Deals & Alliances Report
|
Mar 2011 |
£380 |
96% |
Bayer HealthCare AG
Market Share Analysis
|
Oct 2010 |
£630 |
96% |
|
Bayer HealthCare Integrates OLTP and DWH Through Oracle Exadata for More Efficient Drug Information Analysis
|
Dec 2010 |
£2,215 |
96% |
Bayer AG – Product Pipeline Review
H2 2011
|
Nov 2011 |
£315 |
92% |
|
Liver Cancer Drugs
|
Apr 2010 |
£2,500 |
92% |
|
Partnering Agreements with Baxter 2010
|
Jan 2010 |
£630 |
91% |
